Gazette.govt.nzPursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Hydroxocobalamin |
| Active Ingredient: | Hydroxocobalamin acetate 1.044mg/mL equivalent to hydroxocobalamin 1mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Boucher & Muir (New Zealand) Limited t/a BNM Group |
| Manufacturer: | Delpharm Tours, Chambray Les Tours, France |
|
Note: This consent is given subject to the following conditions:
|
|
| Note: This consent is valid for one year from the date of publication of this notice. | |
| Product: | Vita-B12 Injection |
| Active Ingredient: | Hydroxocobalamin acetate 1.044mg/mL equivalent to hydroxocobalamin 1mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Boucher & Muir (New Zealand) Limited t/a BNM Group |
| Manufacturer: | Delpharm Tours, Chambray Les Tours, France |
|
Note: This consent is given subject to the following conditions:
|
|
| Note: This consent is valid for one year from the date of publication of this notice. | |
Dated this 29th day of October 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).